A common myth is you can't partner until after pha
Post# of 30028
Posted On: 10/14/2015 9:46:12 PM
A common myth is you can't partner until after phase 2 data. I posted about AGTC. It's solely focused on ophthalmology development programs and has proof-of-concept data in multiple indications. AMBS has two ODD in ophthalmology, many areas outside of ophthalmology for MANF, ESS, Elto, Dx...
If you view the Sep 18, 2015 investor presentation here, you can get the whole story, timeline, royalties, etc. http://ir.agtc.com/events.cfm
Did they give away the farm too early?
If you view the Sep 18, 2015 investor presentation here, you can get the whole story, timeline, royalties, etc. http://ir.agtc.com/events.cfm
Did they give away the farm too early?
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼